Search results
Roche withdraws Tecentriq from U.S. bladder cancer indication
Reuters via Yahoo News· 1 year agoZURICH (Reuters) - Roche has voluntarily withdrawn the U.S. indication of Tecentriq for treating a...
Roche (RHHBY) Tecentriq SC Receives Positive CHMP Opinion
Zacks via Yahoo Finance· 6 months agoRoche RHHBY announced that the European Medicines Agency’s Committee for Medicinal Products for...
Roche (RHHBY) Gets EU Nod for Lunsumio, Tecentriq Label Expansion
Zacks via Yahoo Finance· 2 years agoRoche (RHHBY) obtains EU approval for Lunsumio for the treatment of adult patients with relapsed or...
Positive Moderna, Merck cancer vaccine data advances mRNA promise, shares rise
Reuters via Yahoo News· 1 year agoAn experimental cancer vaccine from Moderna Inc based on the messenger RNA (MRNA) technology used in...
Is it a Good Idea to Invest in Harpoon (HARP) Stock Now?
Zacks via Yahoo Finance· 6 months agoHarpoon Therapeutics HARP develops a novel class of T cell engagers, leveraging its proprietary...
20 Countries with the Highest Rates of Skin Cancer
Insider Monkey via Yahoo Finance· 10 months agoIn this article, we’ll take a detailed look at the 20 Countries with the Highest Rates of Skin Cancer. For a quick overview of the top five countries,...
England to rollout world-first seven-minute cancer treatment jab
Reuters via Yahoo News· 9 months agoFollowing approval from the Medicines and Healthcare products Regulatory Agency (MHRA), NHS England...
